Company Overview and News

 
CRU/CESCO-Mantos Copper expanding Chile mine projects despite rising costs

2018-04-10 reuters
SANTIAGO, April 10 (Reuters) - Chilean miner Mantos Copper will go ahead with expansions at two existing copper mines beginning later this year in an effort to grow ahead of rising costs, Chief Executive John Mackenzie told Reuters on Tuesday.

 
All You Need to Know about Vale’s New Dividend Policy

2018-04-09 marketrealist
On March 29, 2018, Vale (VALE) announced a new dividend policy set to take effect in its 1H18 results. The new policy includes the following:

 
Fluor tenders work to Grana y Montero for Quellaveco Peru mine

2018-04-07 reuters
LIMA, April 7 (Reuters) - U.S.-based construction firm Fluor Corp subcontracted earth moving work on the Quellaveco copper mine in Peru to local company Grana y Montero, in a sign the stalled $5 billion project could be reactivated.

 
Market report: Shire shored up by suitor’s confidence

2018-04-06 telegraph.co.uk
Deal-hungry traders lifted pharma takeover target Shire to a fresh three-month high after Japanese suitor Takeda laid the groundwork for a bid.

 
Market report: Growth fears push Boohoo to year low

2018-04-04 telegraph.co.uk
Fast fashion e-tailer Boohoo.com slumped to a 13-month low after City analysts warned that the breakneck speed of its growth could hit the buffers unless it resists the urge to hold back much-needed investment to boost profitability.

 
BHP Billiton upgraded to sector perform from underperform at RBC Capital

2018-04-04 marketwatch
LONDON -- Glencore PLC added to its growing portfolio of coal assets with a $1.7 billion investment in a pair of Australian producers -- part of a bet by the mining giant that demand for coal in Southeast Asia will remain strong, even as competitors shy away from the stuff.

 
Significant statistics

2018-04-04 australianmining.com.au
Australian Mining speaks with several tech luminaries working in the resources sector to discuss the increasing prevalence of tech collaborations that are slowly but surely unpacking the industry’s analytical quandaries.

 
UPDATE 1-UK Stocks-Factors to watch on April 3

2018-04-03 reuters
April 3 (Reuters) - Britain’s FTSE 100 index is seen opening 46 points lower at 7,011 on Tuesday, according to financial bookmakers, with futures down 1.15 percent ahead of the cash market open.

 
UK Stocks-Factors to watch on April 3

2018-04-03 reuters
April 3 (Reuters) - Britain’s FTSE 100 index is seen opening 46 points lower at 7,011 on Tuesday, according to financial bookmakers.

 
GFG Adds Vice President, Exploration Canada

2018-04-02 globenewswire
SASKATOON, Saskatchewan, April 02, 2018 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSX-V:GFG) (OTCQB:GFGSF) (“GFG” or the “Company”) is pleased to announce the appointment of Mr. Rob Mackie as Vice President, Exploration Canada effective immediately. Mr. Mackie will be responsible for leading the Company’s exploration program at its recently acquired Pen Gold and Dore Gold projects located west of the prolific Timmins gold district in Ontario, Canada.

 
Show of state power testing miners’ mettle

2018-03-31 telegraph.co.uk
From the far corners of the globe they came: some of the world’s most powerful mining bosses, summoned to a dull conference room in Kinshasa to plead their case before the president of the Democratic Republic of the Congo.

 
Anglo American ordered to halt Brazil ops again after leak

2018-03-30 reuters
RIO DE JANEIRO (Reuters) - Brazilian environmental regulators ordered miner Anglo American Plc to halt operations in the country in the wake of a pipeline leak, the company said in a statement on Thursday.

 
Hedge fund Fight Over WWII Winning Weapon To Be Decided Today – ValueWalk Premium

2018-03-29 valuewalkpremium
At a time of rising populism in both Europe and the US, the “predatory” hedge fund takeover fight for a UK-based defense company stands out as a benchmark in time. The story has it all: Hedge funds using a capitalist system to root out corporate inefficiency and generate profits, aggressive media reports blasting the deal while rank and file employees who are left shaking their heads as they wonder if at any point those involved care about their jobs and livelihood.

 
UPDATE 1-UK Stocks-Factors to watch on March 28

2018-03-28 reuters
March 28 (Reuters) - Britain’s FTSE 100 index is seen opening 53 points lower on Wednesday, according to financial bookmakers with futures down 0.6 percent ahead of the cash market open.

 
Rio Exits Coal Business With $4 Billion of Deals in a Week - Bloomberg

2018-03-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 03485P201